|Positive WB detected in||mouse kidney tissue, human skeletal muscle tissue|
|Positive IP detected in||mouse kidney tissue|
|Positive IHC detected in||human kidney tissue, human lung tissue, mouse testis tissue, human small intestine tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||mouse kidney tissue|
|Positive FC detected in||NIH/3T3 cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:500-1:2000|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
The immunogen of 21115-1-AP is ACE2 Fusion Protein expressed in E. coli.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||ACE2 fusion protein Ag15455|
|Full Name||angiotensin I converting enzyme (peptidyl-dipeptidase A) 2|
|Calculated molecular weight||805 aa, 92 kDa|
|Observed molecular weight||120 kDa, 92 kDa|
|GenBank accession number||BC048094|
|Gene ID (NCBI)||59272|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
ACE2 (Angiotensin-converting enzyme 2), also named as ACEH, is a zinc metalloprotease of the ACE family and a critical regulator of the reninangiotensin system. ACE2 has a more restricted tissue distribution than ACE, being found predominantly in the heart, kidneys, and testes although low levels have been detected in a variety of tissues (PMID:15983030). ACE2 has been shown to be a functional receptor of the human coronaviruses SARS-CoV and SARS-CoV-2 (PMID: 32142651). The expression level and expression pattern of human ACE2 in different tissues might be critical for the susceptibility, symptoms, and outcome of 2019-nCoV/SARS-CoV-2 infection (PMID: 32133153). It can be used as a potential therapeutic target of SARS-CoV-2 (PMID: 32125455). The calculated molecular weight of ACE2 is 92kDa but it migrates to 120kDa due to N-glycosylation (PMID:16166094). Sometimes, several cleaved fragments can also be detected as 75kDa, 50 kDa or 37kDa (PMID: 29561187, 22009550, 30759273). It has 2 isoforms produced by alternative splicing. This antibody is specific to ACE2. The location of ACE2 is membrane and cytoplasm, however it accumulates in the nucleus during the mitosis (PMID: 1730413/PMID: 18292088).
|Product Specific Protocols|
|WB protocol for ACE2 antibody 21115-1-AP||Download protocol|
|IHC protocol for ACE2 antibody 21115-1-AP||Download protocol|
|IF protocol for ACE2 antibody 21115-1-AP||Download protocol|
|IP protocol for ACE2 antibody 21115-1-AP||Download protocol|
|FC protocol for ACE2 antibody 21115-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Highly Porous Microcarriers for Minimally Invasive In Situ Skeletal Muscle Cell Delivery.
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.
Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.
Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.
Concomitant calciphylaxis and COVID-19 associated thrombotic retiform purpura.
Docked SARS CoV-2 Proteins within the Cutaneous and Subcutaneous Microvasculature and their Role in the Pathogenesis of Severe COVID-19.